Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-14

Clinical Trial Update: A Study of the Effects of Topical Capsaicin in the Treatment of Provoked Vestibulodynia [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating topical capsaicin for provoked vestibulodynia has been terminated after Phase 2/3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • capsaicin (topical) (capsaicin)

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Vestibulodynia | Phase 2, Phase 3 | Status: TERMINATED